The AMS Israel alga-mimetic adhesive platform presents a true breakthrough in the realm of biosurgicals, providing a sophisticated tissue adhesive technology with superior efficacy, safety and ease of use. Mimicking the underwater adherence mechanism of algae, the Sealantis technology platform opens a gateway to a variety of potential applications in surgery, injuries, and drug delivery.

    The platform comprises a protein-free adhesive based on Alginate, a natural polymer produced by algae.

  • The Sealantis alga-mimetic adhesive technology is a viable platform that can be utilized in a variety of indications, relevant to four major applications:

    • Surgical sealing: In many types of surgical procedures, tissue reattachment techniques, such as suturing and stapling, are not leak-proof, resulting in possible leakage of body fluids during and after surgery. AMS Israel develops sealants for surgical leakage control in gastro-intestinal (GI) surgery, neurosurgery, cardio-vascular surgery, lung surgery and other surgical practices.
    • Adhesion prevention and tissue healing: Post-surgical adhesions are a common complication in many types of surgeries and in various orthopedic injuries. The formation of fibrous tissue (scars, adhesions) following trauma to tissues, severely damages the proper recovery and is a major problem from a clinical as well as an economical perspective. AMS Israel develops an innovative approach for preventing adhesions and promoting the functional healing of internal tissues.
    • Surgical adhesion: Using a tissue adhesive to reconnect two planes of tissue resolves an important clinical need, particularly in aesthetic surgeries, such as face and body lifts in which large skin flaps must be reattached. AMS Israel develops a unique solution for tissue adhesion and space-elimination in aesthetic surgery.